Please provide your email address to receive an email when new articles are posted on . U.S. data revealed that cytomegalovirus was independently associated with latent tuberculosis infection, and ...

Classically, detection of IgG antibodies to CMV is diagnostic of past infection and synonymous with the term "seropositivity". Transplant physicians have used this term to predict risk for the ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of ...

Biotest AG: Biotest treats first CMV-positive pregnant woman in Phase III clinical trial to prevent transmission of CMV infection to the unborn child 14.12.2021 / 07:00 The issuer is solely ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of ...

Hookipa (NASDAQ:HOOK) announces positive interim data from a Phase 2 clinical trial evaluating cytomegalovirus (CMV) vaccine candidate HB-101 in patients receiving a transplanted kidney from a live ...

—These investigators explored associations among early-life and in utero infections and cytomegalovirus-positive acute lymphoblastic leukemia in children, with signs pointing to underlying immune ...

Phase 2 study to confirm dose to be initiated in near term, with planned interim analysis through 3 months; Phase 3 study planning is underway CMV is the most common infectious cause of birth defects ...